drug is weak and low-effective, sales in Japan are very modest, more cheaper and may be more effective drug in late phase III trial and etcetera...read here:http://www.biotechinvest.net/itmn.html
What a example of this way way overpriced stock. Comes Monday this will no doubt what so ever be back at the low teens. This is hard core evidence. Longs better sell or loose.
Why does everyone on yahoo message boards spell "lose" loose. I am no great speller either but geewhiz.